Anti-CD19/BCMA CAR-NK cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-CD19/BCMA CAR-NK cells, covering 2025-12-01 to 2025-12-01. Get the full timeline:
Most recent: Clinical Trial Update: Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease [EARLY_Phase 1]